Stay updated with breaking news from Revascularization Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Penumbra, Inc. (NYSE:PEN – Get Free Report) Director Surbhi Sarna sold 85 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $247.68, for a total value of $21,052.80. Following the sale, the director now directly owns 2,295 shares in the company, valued at $568,425.60. […]
Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twelve analysts that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1-year […]
Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12-month […]
Penumbra (NYSE:PEN – Free Report) had its price target boosted by JPMorgan Chase & Co. from $240.00 to $284.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. A number of other brokerages also recently weighed in on PEN. Morgan Stanley cut […]
Azimuth Capital Investment Management LLC trimmed its position in Penumbra, Inc. (NYSE:PEN – Free Report) by 1.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,509 shares of the company’s stock after selling 451 shares during the period. Azimuth […]